BDTX

BDTX

USD

Black Diamond Therapeutics Inc. Common Stock

$2.375+0.025 (1.064%)

Echtzeitkurs

Healthcare
Biotechnologie
Vereinigte Staaten

Kursdiagramm

Loading Chart...

Schlüsselkennzahlen

Marktkennzahlen
Unternehmensfundamentaldaten
Handelsstatistiken

Marktkennzahlen

Eröffnung

$2.350

Hoch

$2.380

Tief

$2.300

Volumen

0.56M

Unternehmensfundamentaldaten

Marktkapitalisierung

135.0M

Branche

Biotechnologie

Land

United States

Handelsstatistiken

Durchschnittliches Volumen

3.50M

Börse

NMS

Währung

USD

52-Wochen-Spanne

Tief $1.195Aktuell $2.375Hoch $6.75

Ähnliche Nachrichten

GlobeNewswire

Servier and Black Diamond Therapeutics Announce Global Licensing Agreement for BDTX-4933, A Targeted Oncology Therapy

The partnership underscores Servier's commitment to developing targeted therapies that address unmet medical needs in oncologyServier will develop and commercialize BDTX-4933, a Phase 1 asset with best-in-class potential

Mehr anzeigen
Servier and Black Diamond Therapeutics Announce Global Licensing Agreement for BDTX-4933, A Targeted Oncology Therapy
Analyst Upgrades

HC Wainwright & Co. Maintains Buy on Black Diamond Therapeutic, Raises Price Target to $12

HC Wainwright & Co. analyst Robert Burns maintains Black Diamond Therapeutic with a Buy and raises the price target from $11 to $12.

Mehr anzeigen
HC Wainwright & Co. Maintains Buy on Black Diamond Therapeutic, Raises Price Target to $12
Analyst Upgrades

Stifel Maintains Buy on Black Diamond Therapeutic, Lowers Price Target to $15

Stifel analyst Bradley Canino maintains Black Diamond Therapeutic with a Buy and lowers the price target from $16 to $15.

Mehr anzeigen
Stifel Maintains Buy on Black Diamond Therapeutic, Lowers Price Target to $15